The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 14, 2020

Filed:

Jul. 07, 2017
Applicants:

University of Maryland, Baltimore, Baltimore, MD (US);

The United States of America As Represented BY the Department of Veterans Affairs, Washington, DC (US);

Inventors:

J. Marc Simard, Baltimore, MD (US);

Mingkui Chen, Lake Forest, IL (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61P 9/10 (2006.01); A61K 31/165 (2006.01); A61K 31/565 (2006.01); A61K 31/566 (2006.01); G01N 33/50 (2006.01); C12N 5/079 (2010.01); A61K 49/00 (2006.01); A61K 31/00 (2006.01); A61K 31/175 (2006.01); A61K 31/426 (2006.01); A61K 31/4439 (2006.01); A61K 31/64 (2006.01); B01J 19/00 (2006.01); B32B 37/12 (2006.01); C07K 14/705 (2006.01); G01N 33/68 (2006.01); A61K 31/18 (2006.01); A61K 31/195 (2006.01); A61K 31/197 (2006.01); A61K 31/4015 (2006.01); A61K 31/403 (2006.01); A61K 31/4453 (2006.01); A61K 31/7076 (2006.01); B29L 31/00 (2006.01);
U.S. Cl.
CPC ...
G01N 33/5058 (2013.01); A61K 31/00 (2013.01); A61K 31/175 (2013.01); A61K 31/18 (2013.01); A61K 31/195 (2013.01); A61K 31/197 (2013.01); A61K 31/403 (2013.01); A61K 31/4015 (2013.01); A61K 31/426 (2013.01); A61K 31/4439 (2013.01); A61K 31/4453 (2013.01); A61K 31/64 (2013.01); A61K 31/7076 (2013.01); A61K 49/0008 (2013.01); B01J 19/0093 (2013.01); B32B 37/1292 (2013.01); C07K 14/705 (2013.01); C12N 5/0622 (2013.01); G01N 33/5076 (2013.01); G01N 33/6872 (2013.01); B29L 2031/756 (2013.01); G01N 2500/04 (2013.01); Y10S 514/87 (2013.01);
Abstract

A composition comprising a novel Ca-activated, [ATP]-sensitive nonspecific cation (NC) channel is described. The channel is found in mammalian neural cells and exhibits a different sensitivity to block by various adenine nucleotides, and is activated by submicromolar [Ca]. The NCchannel is activated under conditions of ATP depletion, which causes severe cell depolarization, followed by cell swelling. The NCchannel is regulated by a sulfonylurea receptor and is inhibited by sulfonylurea compounds glibenclamide and tolbutamide. Methods employing compositions comprising the NCchannel to screen for compounds that block the channel and the use of such antagonists as therapeutics in preventing brain swelling and damage are described. In addition, methods employing compositions comprising the Kir2.3 channel to screen for compounds that open the channel and the use of such antagonists as therapeutics in preventing brain swelling and damage are described.


Find Patent Forward Citations

Loading…